Craig J. Burd, Ph.D.
Affiliations: | 2006 | University of Cincinnati, Cincinnati, OH |
Area:
Molecular Biology, Cell BiologyGoogle:
"Craig Burd"Parents
Sign in to add mentorKaren E. Knudsen | grad student | 2006 | University of Cincinnati | |
(Prostatic regulation of the androgen receptor by cyclin D1: Function and dysfunction.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
N Haines C, Klingensmith HD, Komara M, et al. (2020) GREB1 regulates PI3K/Akt signaling to control hormone-sensitive breast cancer proliferation. Carcinogenesis |
Haines CN, Braunreiter KM, Mo XM, et al. (2018) GREB1 isoforms regulate proliferation independent of ERα co-regulator activities in breast cancer. Endocrine-Related Cancer |
Augello MA, Burd CJ, Birbe R, et al. (2013) Convergence of oncogenic and hormone receptor pathways promotes metastatic phenotypes. The Journal of Clinical Investigation. 123: 493-508 |
Burd CJ, Ward JM, Crusselle-Davis VJ, et al. (2012) Analysis of chromatin dynamics during glucocorticoid receptor activation. Molecular and Cellular Biology. 32: 1805-17 |
Augello MA, Burd C, Bribe R, et al. (2012) Abstract A50: Cyclin D1 isoforms selectively manipulate AR signaling to promote metastatic phenotypes in early and castration-resistant prostate cancer. Cancer Research. 72: A50-A50 |
Comstock CE, Augello MA, Schiewer MJ, et al. (2011) Cyclin D1 is a selective modifier of androgen-dependent signaling and androgen receptor function. The Journal of Biological Chemistry. 286: 8117-27 |
Augello M, Burd C, Karch J, et al. (2010) Abstract 3878: Perturbations in the AR-cyclin D1 axis controls lethal tumor phenotypes in prostate cancer Cancer Research. 70: 3878-3878 |
Comstock CE, Augello MA, Benito RP, et al. (2009) Cyclin D1 splice variants: polymorphism, risk, and isoform-specific regulation in prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 5338-49 |
Schiewer MJ, Morey LM, Burd CJ, et al. (2009) Cyclin D1 repressor domain mediates proliferation and survival in prostate cancer Oncogene. 28: 1016-1027 |
Wang Y, Dean JL, Millar EK, et al. (2008) Cyclin D1b is aberrantly regulated in response to therapeutic challenge and promotes resistance to estrogen antagonists. Cancer Research. 68: 5628-38 |